Tokyo Tape
Sign in
← OLBA Healthcare Holdings

Quarterly report · Q3

2689.TEDINET S100TDQB
Period2023-07-01 → 2024-03-31
Filed2024-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥89.4bn2023-07-01 → 2024-03-31Cons.Net sales
Revenue¥110.5bn2022-07-01 → 2023-06-30Cons.Net sales (5-year summary)
Revenue¥82.9bn2022-07-01 → 2023-03-31Cons.Net sales
Operating income¥1.7bn2023-07-01 → 2024-03-31Cons.Operating income
Operating income¥1.6bn2022-07-01 → 2023-03-31Cons.Operating income
Ordinary income¥1.7bn2023-07-01 → 2024-03-31Cons.Ordinary income
Ordinary income¥2.2bn2022-07-01 → 2023-06-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.6bn2022-07-01 → 2023-03-31Cons.Ordinary income
Profit before tax¥1.7bn2023-07-01 → 2024-03-31Cons.Income before income taxes
Profit before tax¥1.6bn2022-07-01 → 2023-03-31Cons.Income before income taxes
Net income (owners)¥1.1bn2023-07-01 → 2024-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.4bn2022-07-01 → 2023-06-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.0bn2022-07-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income¥1.1bn2023-07-01 → 2024-03-31Cons.Profit loss
Net income¥1.0bn2022-07-01 → 2023-03-31Cons.Profit loss
Total assets¥46.1bnat 2024-03-31Cons.Assets
Total assets¥40.9bnat 2023-06-30Cons.Assets
Total assets¥41.9bnat 2023-03-31Cons.Total assets (5-year summary)
Total liabilities¥35.3bnat 2024-03-31Cons.Liabilities
Total liabilities¥30.6bnat 2023-06-30Cons.Liabilities
Net assets / equity¥10.8bnat 2024-03-31Cons.Net assets
Net assets / equity¥10.3bnat 2023-06-30Cons.Net assets
Net assets / equity¥9.8bnat 2023-03-31Cons.Net assets (5-year summary)
Cash and deposits¥3.2bnat 2024-03-31Cons.Cash and deposits
Cash and deposits¥2.4bnat 2023-06-30Cons.Cash and deposits
EPS (basic)¥186.642023-07-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥106.352024-01-01 → 2024-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥234.92022-07-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥171.792022-07-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥80.662023-01-01 → 2023-03-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio23.4%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio25.3%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio23.3%at 2023-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-07-01 → 2024-03-31−¥1.1bn
Reconciling Itemsreconcilingrevenue intersegment2023-07-01 → 2024-03-31−¥1.1bn
Reconciling Itemsreconcilingsegment profit2023-07-01 → 2024-03-31−¥99m
jpcrp040300-q3r_E02928-000Care Nursing Goodsreportable segmentrevenue2023-07-01 → 2024-03-31¥2.0bn
jpcrp040300-q3r_E02928-000Care Nursing Goodsreportable segmentrevenue external2023-07-01 → 2024-03-31¥2.0bn
jpcrp040300-q3r_E02928-000Care Nursing Goodsreportable segmentrevenue intersegment2023-07-01 → 2024-03-31¥1m
jpcrp040300-q3r_E02928-000Care Nursing Goodsreportable segmentsegment profit2023-07-01 → 2024-03-31¥150m
jpcrp040300-q3r_E02928-000Medical Equipmentreportable segmentrevenue2023-07-01 → 2024-03-31¥84.6bn
jpcrp040300-q3r_E02928-000Medical Equipmentreportable segmentrevenue external2023-07-01 → 2024-03-31¥83.7bn
jpcrp040300-q3r_E02928-000Medical Equipmentreportable segmentrevenue intersegment2023-07-01 → 2024-03-31¥983m
jpcrp040300-q3r_E02928-000Medical Equipmentreportable segmentsegment profit2023-07-01 → 2024-03-31¥1.6bn
jpcrp040300-q3r_E02928-000SPDreportable segmentrevenue2023-07-01 → 2024-03-31¥3.9bn
jpcrp040300-q3r_E02928-000SPDreportable segmentrevenue external2023-07-01 → 2024-03-31¥3.8bn
jpcrp040300-q3r_E02928-000SPDreportable segmentrevenue intersegment2023-07-01 → 2024-03-31¥100m
jpcrp040300-q3r_E02928-000SPDreportable segmentsegment profit2023-07-01 → 2024-03-31¥84m
Total Of Reportable Segments And Otherssegment totalrevenue2023-07-01 → 2024-03-31¥90.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-07-01 → 2024-03-31¥89.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-07-01 → 2024-03-31¥1.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-07-01 → 2024-03-31¥1.8bn
Reconciling Itemsreconcilingrevenue2022-07-01 → 2023-03-31−¥1.2bn
Reconciling Itemsreconcilingrevenue intersegment2022-07-01 → 2023-03-31−¥1.2bn
Reconciling Itemsreconcilingsegment profit2022-07-01 → 2023-03-31−¥94m
jpcrp040300-q3r_E02928-000Care Nursing Goodsreportable segmentrevenue2022-07-01 → 2023-03-31¥1.9bn
jpcrp040300-q3r_E02928-000Care Nursing Goodsreportable segmentrevenue external2022-07-01 → 2023-03-31¥1.9bn
jpcrp040300-q3r_E02928-000Care Nursing Goodsreportable segmentrevenue intersegment2022-07-01 → 2023-03-31¥554,000
jpcrp040300-q3r_E02928-000Care Nursing Goodsreportable segmentsegment profit2022-07-01 → 2023-03-31¥142m
jpcrp040300-q3r_E02928-000Medical Equipmentreportable segmentrevenue2022-07-01 → 2023-03-31¥78.3bn
jpcrp040300-q3r_E02928-000Medical Equipmentreportable segmentrevenue external2022-07-01 → 2023-03-31¥77.2bn
jpcrp040300-q3r_E02928-000Medical Equipmentreportable segmentrevenue intersegment2022-07-01 → 2023-03-31¥1.1bn
jpcrp040300-q3r_E02928-000Medical Equipmentreportable segmentsegment profit2022-07-01 → 2023-03-31¥1.4bn
jpcrp040300-q3r_E02928-000SPDreportable segmentrevenue2022-07-01 → 2023-03-31¥3.9bn
jpcrp040300-q3r_E02928-000SPDreportable segmentrevenue external2022-07-01 → 2023-03-31¥3.8bn
jpcrp040300-q3r_E02928-000SPDreportable segmentrevenue intersegment2022-07-01 → 2023-03-31¥95m
jpcrp040300-q3r_E02928-000SPDreportable segmentsegment profit2022-07-01 → 2023-03-31¥148m
Total Of Reportable Segments And Otherssegment totalrevenue2022-07-01 → 2023-03-31¥84.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-07-01 → 2023-03-31¥82.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-07-01 → 2023-03-31¥1.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-07-01 → 2023-03-31¥1.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 348
ItemContextValueUnit
Net defined benefit liabilityPrior1YearInstant444149000JPY
Net defined benefit liabilityCurrentQuarterInstant469453000JPY
Long term accounts payable otherPrior1YearInstant175077000JPY
Long term accounts payable otherCurrentQuarterInstant148000000JPY
Other nclPrior1YearInstant1110355000JPY
Other nclCurrentQuarterInstant1229903000JPY
Noncurrent liabilitiesPrior1YearInstant1957725000JPY
Noncurrent liabilitiesCurrentQuarterInstant2113409000JPY
LiabilitiesPrior1YearInstant30550538000JPY
LiabilitiesCurrentQuarterInstant35324135000JPY
Capital stockPrior1YearInstant607750000JPY
Capital stockCurrentQuarterInstant607750000JPY
Capital surplusPrior1YearInstant321534000JPY
Capital surplusCurrentQuarterInstant321534000JPY
Retained earningsPrior1YearInstant9416474000JPY
Retained earningsCurrentQuarterInstant10095655000JPY
Treasury stockPrior1YearInstant-342042000JPY
Treasury stockCurrentQuarterInstant-557173000JPY
Shareholders equityPrior1YearInstant10003715000JPY
Shareholders equityCurrentQuarterInstant10467766000JPY
Valuation difference on available for sale securitiesPrior1YearInstant137135000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant167218000JPY
Remeasurements of defined benefit plansPrior1YearInstant186792000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant171976000JPY
Valuation and translation adjustmentsPrior1YearInstant323927000JPY
Valuation and translation adjustmentsCurrentQuarterInstant339194000JPY
Non controlling interestsPrior1YearInstant－JPY
Non controlling interestsCurrentQuarterInstant－JPY
Net assetsPrior1YearInstant10327643000JPY
Net assetsCurrentQuarterInstant10806960000JPY
Liabilities and net assetsPrior1YearInstant40878181000JPY
Liabilities and net assetsCurrentQuarterInstant46131096000JPY
Net salesPrior1YTDDuration82852973000JPY
Net salesCurrentYTDDuration89402107000JPY
Cost of salesPrior1YTDDuration73265787000JPY
Cost of salesCurrentYTDDuration79218003000JPY
Gross profitPrior1YTDDuration9587186000JPY
Gross profitCurrentYTDDuration10184104000JPY
Selling general and administrative expensesPrior1YTDDuration8014111000JPY
Selling general and administrative expensesCurrentYTDDuration8497678000JPY
Operating incomePrior1YTDDuration1573074000JPY
Operating incomeCurrentYTDDuration1686425000JPY
Interest income noiPrior1YTDDuration203000JPY
Interest income noiCurrentYTDDuration2245000JPY
Dividends income noiPrior1YTDDuration912000JPY
Dividends income noiCurrentYTDDuration1056000JPY
Insurance income noiPrior1YTDDuration376000JPY
Insurance income noiCurrentYTDDuration4737000JPY
Commission fee noiPrior1YTDDuration1111000JPY
Commission fee noiCurrentYTDDuration1176000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-06-30pass
balance sheet identityconsolidated 2024-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-07-01/2024-03-31pass
statement vs summary · revenueconsolidated 2022-07-01/2023-03-31pass
statement vs summary · revenueconsolidated 2023-07-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass